Symbiox Investment & Trading Co Board Meeting Date
SYMBIOX INVESTMENT & TRADING CO. LTD intimated a board meeting on 13 Nov 2026 to consider unaudited standalone quarterly results for September 2026. Trading window closed from 01 Oct to 13 Nov 2026.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
16 announcements
SYMBIOX INVESTMENT & TRADING CO. LTD intimated a board meeting on 13 Nov 2026 to consider unaudited standalone quarterly results for September 2026. Trading window closed from 01 Oct to 13 Nov 2026.
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) as mandated by SEBI regulations. This filing contains no material business events or corporate transactions.
Symbiox Investment & Trading Company Ltd held its 47th Annual General Meeting on September 28, 2026. Shareholders adopted audited financial statements and re-appointed Mrs. Sunita Show as Director.
Symbiox Investment & Trading Company Ltd submitted its 47th Annual Report for the financial year 2025-26. The report includes the notice for the upcoming Annual General Meeting.
Symbiox Investment & Trading Company Ltd has issued a circular to shareholders providing the web-link and access path for its FY 2025-26 Annual Report.
Symbiox Investment & Trading Company Ltd will hold its 47th Annual General Meeting on September 28, 2026. The agenda includes adopting FY26 financial statements and director re-appointment.
Symbiox Investment & Trading Co. Ltd announced its 47th Annual General Meeting for September 28, 2026. The board approved the director's report and e-voting schedules.
Symbiox Investment & Trading Co. Ltd. will hold a Board Meeting on August 26, 2026. The agenda includes approving the Director Report and scheduling the AGM.
Symbiox Investment & Trading Co. Ltd reported revenue from operations of ₹0.3 Cr (-40.0% YoY) and net profit of ₹0.1 Cr (+0.0% YoY) for Q1 FY27.
Symbiox Investment & Trading Co. Ltd has scheduled a board meeting for August 12, 2026. The board will consider unaudited standalone financial results for the June 2026 quarter.
Symbiox Investment & Trading Co. submitted its Annual Secretarial Compliance Report for FY26. The auditor noted previous non-compliance regarding shareholding pattern filings at BSE and MCX.
Symbiox Investment approved FY2026 audited results and re-appointed its secretarial and internal auditors. The meeting concluded at 02:55 P.M. with no material financial impact noted.
Symbiox Investment & Trading Co. Ltd reported revenue from operations of ₹0.8 Cr (-33.3% YoY) and net profit of ₹0 Cr for Q4 FY26.
Symbiox Investment & Trading approved audited FY2026 results and re-appointed its secretarial and internal auditors. The board meeting concluded at 02:55 P.M. with unmodified audit opinions.
Symbiox Investment & Trading Co Ltd scheduled a board meeting for May 23, 2026. Directors will consider audited financial results and various auditor appointments.
Symbiox Investment & Trading Co Ltd informed exchanges that it is not identified as a 'Large Corporate' as of March 31, 2026. This disclosure confirms the company is exempt from specific SEBI debt-raising requirements for large entities.